abo incompatibility neonatal jaundice With both father and mother Rh positive
Reading File
Finding Sources
Searching PubMed
ABO incompatibility hemolytic disease newborn
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Now I have enough information for a comprehensive answer. Let me compile everything.
ABO Incompatibility and Neonatal Jaundice - When Both Parents are Rh Positive
Why Rh Status is Irrelevant Here
This is a key concept worth clarifying upfront: the Rh (Rhesus) system and the ABO system are completely separate blood group systems. Both parents being Rh positive means there is no risk of Rh (anti-D) hemolytic disease - but it says nothing about ABO compatibility. ABO incompatibility jaundice depends entirely on the ABO blood groups of the mother and baby, not the Rh type.
How ABO Incompatibility Causes HDN
The Classic Setup:
- Mother: Blood group O
- Baby: Blood group A or B (inherited from the father)
Group O mothers naturally produce anti-A and anti-B isohemagglutinins. Normally these are IgM (too large to cross the placenta), but for reasons not fully understood, some group O women carry IgG anti-A or anti-B antibodies even without prior sensitization or pregnancy. These IgG antibodies can freely cross the placenta and attack fetal red cells.
"ABO hemolytic disease occurs almost exclusively in infants of blood group A or B who are born to mothers of blood group O. The normal anti-A and anti-B isohemagglutinins in group O mothers usually are of the IgM type and therefore do not cross the placenta. However, for reasons not well understood, some group O women possess IgG antibodies directed against group A or B antigens even without previous sensitization. Therefore, the firstborn may be affected."
- Robbins & Kumar Basic Pathology
Why ABO is Now the Most Common HDN
With the success of Rh immune globulin (RhIg) prophylaxis, Rh incompatibility disease has been dramatically reduced. ABO incompatibility is now the most common cause of immune hemolytic disease of the newborn (HDN).
- ABO incompatibility occurs in ~15-25% of all pregnancies (where mother is group O and baby is A or B)
- But clinical hemolytic disease develops in only about 3% of all births
- The disease tends to be milder than Rh HDN, partly because A and B antigens are widely expressed on many cell types, acting like a sponge for the transferred antibody
Key Features of ABO HDN
| Feature | ABO Incompatibility | Rh Incompatibility |
|---|---|---|
| Prior sensitization needed | No - can affect firstborn | Yes - usually spares first pregnancy |
| Antibody type | IgG anti-A or anti-B | IgG anti-D |
| Severity | Usually mild-moderate | Potentially severe (hydrops) |
| Spherocytosis on smear | Prominent | Less common |
| Direct Coombs (DAT) | Weakly positive | Strongly positive |
| Hydrops fetalis | Rare | Can occur in severe cases |
Clinical Presentation
- Jaundice - typically appears within the first 24-48 hours (early onset is a red flag)
- Mild to moderate anemia
- Reticulocytosis (elevated reticulocyte count)
- Spherocytes on peripheral smear - a hallmark distinguishing it from Rh HDN
- Hepatosplenomegaly is less common than in Rh disease
- No anemia may be present at all in some cases
Risk of Kernicterus
Even though ABO HDN is milder, untreated severe hyperbilirubinemia can still cause kernicterus - deposition of unconjugated bilirubin in the basal ganglia and brainstem nuclei, leading to:
- Choreoathetosis and spastic quadriplegia
- Mental retardation
- Sensorineural hearing loss
Risk factors amplifying this danger include prematurity, low albumin, acidosis, and infection.
Diagnosis
- Blood group mismatch - Group O mother, Group A or B infant
- Direct Antiglobulin Test (DAT/Coombs) - weakly positive on infant's red cells
- Eluate from infant's RBCs - contains anti-A or anti-B antibody
- Maternal serum - high titers of IgG anti-A or anti-B
- Peripheral smear - spherocytes, reticulocytes
- Serum bilirubin - rising indirect (unconjugated) bilirubin
"There is no effective method of preventing hemolytic disease resulting from ABO incompatibility."
- Robbins & Kumar Basic Pathology
Management
| Intervention | Indication |
|---|---|
| Phototherapy | First-line for elevated bilirubin; converts unconjugated bilirubin to water-soluble isomers |
| Intravenous Immunoglobulin (IVIG) | Reduces hemolysis by blocking Fc receptors; can reduce need for exchange transfusion |
| Exchange transfusion | Reserved for severe hyperbilirubinemia not responding to phototherapy; risk of kernicterus |
| Serial bilirubin monitoring | Hourly-of-life nomogram guides treatment thresholds |
| Parental education + close follow-up | Key element in prevention of severe jaundice |
Summary Table: ABO vs. Rh in Your Scenario
| Factor | In This Case |
|---|---|
| Father Rh+ / Mother Rh+ | No Rh HDN possible - baby will be Rh positive, no maternal sensitization |
| ABO incompatibility risk | Fully possible - if mother is group O and baby is A or B |
| Mechanism | Maternal IgG anti-A/B crosses placenta, destroys fetal RBCs |
| Prevention | None effective (unlike Rh disease, no equivalent of RhIg exists) |
Key takeaway: When a clinician says "both parents are Rh positive" to rule out hemolytic jaundice, that reasoning is incomplete. ABO incompatibility must still be investigated, and it is the most common immune cause of neonatal jaundice today.
Sources: Robbins & Kumar Basic Pathology; Henry's Clinical Diagnosis and Management by Laboratory Methods; Creasy & Resnik's Maternal-Fetal Medicine
This is a shared conversation. Sign in to Orris to start your own chat.